Drug Patent Expirations in October 2015

Drug Patent Expirations for October 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
PRILOSEC OTC Astrazeneca Pharms omeprazole magnesium 5,817,338 Oct 6, 2015
LETAIRIS Gilead ambrisentan 7,109,205 Oct 7, 2015
LETAIRIS Gilead ambrisentan 7,601,730 Oct 7, 2015
LETAIRIS Gilead ambrisentan 8,349,843 Oct 7, 2015
NAMENDA XR Forest Labs Llc memantine hydrochloride 5,061,703*PED Oct 11, 2015
NAMZARIC Forest Labs Llc donepezil hydrochloride; memantine hydrochloride 5,061,703*PED Oct 11, 2015
NAMENDA Forest Labs Llc memantine hydrochloride 5,061,703*PED Oct 11, 2015
ALOXI Helsinn Hlthcare palonosetron hydrochloride 5,202,333*PED Oct 13, 2015
VARITHENA Provensis polidocanol RE40640 Oct 14, 2015
SENSIPAR Amgen cinacalcet hydrochloride 6,211,244 Oct 23, 2015
FROVA Endo Pharms frovatriptan succinate 5,827,871 Oct 27, 2015
LIDODERM Teikoku Pharma Usa lidocaine 5,827,529 Oct 27, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2015 Biotechblog

Comments are closed.

%d bloggers like this: